Beutel, Goodman & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $228M | Sell |
649,319
-533,134
| -45% | -$190M | 1.55% | 29 |
|
|
2025
Q4 | $387M | Sell |
1,182,453
-264,477
| -18% | -$83.9M | 2.38% | 12 |
|
|
2025
Q3 | $408M | Buy |
1,446,930
+10,308
| +0.7% | +$2.99M | 2.46% | 8 |
|
|
2025
Q2 | $401M | Buy |
1,436,622
+37,343
| +3% | +$10.6M | 2.29% | 14 |
|
|
2025
Q1 | $436M | Buy |
1,399,279
+126,854
| +10% | +$37.5M | 2.51% | 8 |
|
|
2024
Q4 | $332M | Buy |
1,272,425
+172,542
| +16% | +$51.2M | 1.8% | 25 |
|
|
2024
Q3 | $354M | Sell |
1,099,883
-573,408
| -34% | -$188M | 1.75% | 26 |
|
|
2024
Q2 | $523M | Buy |
1,673,291
+82,036
| +5% | +$24.1M | 2.78% | 5 |
|
|
2024
Q1 | $452M | Buy |
1,591,255
+21,598
| +1% | +$6.32M | 2.33% | 13 |
|
|
2023
Q4 | $452M | Sell |
1,569,657
-5,985
| -0.4% | -$1.63M | 2.4% | 12 |
|
|
2023
Q3 | $423M | Sell |
1,575,642
-300
| -0% | -$74.9K | 2.5% | 13 |
|
|
2023
Q2 | $350M | Buy |
1,575,942
+204,486
| +15% | +$47.4M | 1.96% | 19 |
|
|
2023
Q1 | $332M | Buy |
1,371,456
+28,165
| +2% | +$6.91M | 1.95% | 18 |
|
|
2022
Q4 | $353M | Sell |
1,343,291
-197,888
| -13% | -$53M | 2.14% | 16 |
|
|
2022
Q3 | $347M | Sell |
1,541,179
-128,762
| -8% | -$31.2M | 2.35% | 14 |
|
|
2022
Q2 | $406M | Buy |
1,669,941
+48,505
| +3% | +$11.9M | 2.52% | 11 |
|
|
2022
Q1 | $392M | Buy |
1,621,436
+46,105
| +3% | +$10.6M | 2.22% | 13 |
|
|
2021
Q4 | $354M | Buy |
1,575,331
+97,584
| +7% | +$20.6M | 2.02% | 18 |
|
|
2021
Q3 | $314M | Buy |
1,477,747
+119,022
| +9% | +$27.4M | 1.92% | 20 |
|
|
2021
Q2 | $331M | Buy |
1,358,725
+147,292
| +12% | +$36.2M | 1.97% | 17 |
|
|
2021
Q1 | $301M | Buy |
1,211,433
+182,472
| +18% | +$43.5M | 1.89% | 16 |
|
|
2020
Q4 | $237M | Buy |
1,028,961
+412,976
| +67% | +$95.2M | 1.6% | 22 |
|
|
2020
Q3 | $157M | Sell |
615,985
-243,516
| -28% | -$60.3M | 1.26% | 30 |
|
|
2020
Q2 | $203M | Sell |
859,501
-109,996
| -11% | -$25.1M | 1.67% | 19 |
|
|
2020
Q1 | $197M | Sell |
969,497
-82,117
| -8% | -$17.9M | 1.83% | 16 |
|
|
2019
Q4 | $254M | Sell |
1,051,614
-4,770
| -0.5% | -$1.05M | 1.45% | 16 |
|
|
2019
Q3 | $154M | Sell |
1,056,384
-44,127
| -4% | -$8.47M | 1.08% | 26 |
|
|
2019
Q2 | $155M | Buy |
1,100,511
+369,142
| +50% | +$66.1M | 1.12% | 23 |
|
|
2019
Q1 | $104M | Buy |
731,369
+65,821
| +10% | +$12.6M | 0.78% | 34 |
|
|
2018
Q4 | $94.9M | Buy |
665,548
+56,365
| +9% | +$11M | 0.81% | 31 |
|
|
2018
Q3 | $97.7M | Sell |
609,183
-8,347
| -1% | -$1.64M | 0.71% | 34 |
|
|
2018
Q2 | $86.7M | Buy |
+617,530
| New | +$109M | 0.64% | 38 |
|
Other funds holding AMGN
VCM
VPM
Beutel, Goodman & Co's AMGN Position: Q1 2026 in Review
Beutel, Goodman & Co reduced its Amgen (AMGN) stake by 45% in Q1 2026, selling an estimated $190M and leaving 649,319 shares worth $228M. The position accounts for 1.55% of the portfolio, ranked #29.
Beutel, Goodman & Co first reported a position in AMGN in Q2 2018 and has held it in 32 quarters since. The position peaked at $523M in Q2 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Beutel, Goodman & Co held 649,319 shares of Amgen worth $228M as of Q1 2026.
- Beutel, Goodman & Co sold 533,134 Amgen shares in Q1 2026, an estimated $190M.
- Amgen made up 1.55% of Beutel, Goodman & Co's portfolio in Q1 2026, its #29 holding.
- Beutel, Goodman & Co first reported a position in Amgen in Q2 2018 and has held it in 32 quarters since.
- Beutel, Goodman & Co's Amgen position peaked at $523M in Q2 2024.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Beutel, Goodman & Co's 13F filing for Q1 2026, filed 15 May 2026.